Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.

ABSTRACT:

Objective

Cervical cancer remains the most common cancer among women in sub-Saharan Africa and is also a leading cause of cancer related deaths among these women. The benefit of chemoradiation in comparison with radiation alone for patients with stage IIIB disease has not been evaluated prospectively in women living with human immunodeficiency virus (HIV). We assessed the survival of chemoradiation versus radiation alone among stage IIIB cervical cancer patients based on HIV status.

Methods

Between February 2013 and June 2018, patients with International Federation of Gynecology and Obstetrics (FIGO) 2009 stage IIIB cervical cancer with or without HIV and treated with chemoradiation or radiation alone, were prospectively enrolled in an observational cohort study. Overall sur

SUBMITTER: Grover S 

PROVIDER: S-EPMC8675879 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature